Cancer stem cells (CSCs; also known as tumour initiating cells) are a small population of cancer cells that retain characteristics similar to those of normal stem cells. CSCs are known to be responsible for metastasis, drug resistance and cancer recurrence. The lineages assumed by stem cells during hematopoiesis can be identified by the pattern of protein markers present on the surface of cells at different stages of differentiation. CSC surface markers provide molecular targeted therapies for various cancers, using therapeutic antibodies specific for the CSC surface markers. Moreover, the potential role of these cells in differentiation, treatment resistance, relapse and metastasis suggests that elimination of these cells can be a novel approach for oral cancer therapy. The combination of surgery, chemotherapy and radiation therapy has managed in controlling the disease, but overall the five year survival rate is poor. Hence along with these treatment modalities, controlling CSCs can prevent recurrence and increases overall disease free survival rate.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Cancer stem cells (CSCs; also known as tumour initiating cells) are a small population of cancer cells that retain characteristics similar to those of normal stem cells. CSCs are known to be responsible for metastasis, drug resistance and cancer recurrence. The lineages assumed by stem cells during hematopoiesis can be identified by the pattern of protein markers present on the surface of cells at different stages of differentiation. CSC surface markers provide molecular targeted therapies for various cancers, using therapeutic antibodies specific for the CSC surface markers. Moreover, the potential role of these cells in differentiation, treatment resistance, relapse and metastasis suggests that elimination of these cells can be a novel approach for oral cancer therapy. The combination of surgery, chemotherapy and radiation therapy has managed in controlling the disease, but overall the five year survival rate is poor. Hence along with these treatment modalities, controlling CSCs can prevent recurrence and increases overall disease free survival rate. 136 pp. Englisch. N° de réf. du vendeur 9786204733814
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. N° de réf. du vendeur 560259852
Quantité disponible : Plus de 20 disponibles
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Cancer stem cells (CSCs; also known as tumour initiating cells) are a small population of cancer cells that retain characteristics similar to those of normal stem cells. CSCs are known to be responsible for metastasis, drug resistance and cancer recurrence. The lineages assumed by stem cells during hematopoiesis can be identified by the pattern of protein markers present on the surface of cells at different stages of differentiation. CSC surface markers provide molecular targeted therapies for various cancers, using therapeutic antibodies specific for the CSC surface markers. Moreover, the potential role of these cells in differentiation, treatment resistance, relapse and metastasis suggests that elimination of these cells can be a novel approach for oral cancer therapy. The combination of surgery, chemotherapy and radiation therapy has managed in controlling the disease, but overall the five year survival rate is poor. Hence along with these treatment modalities, controlling CSCs can prevent recurrence and increases overall disease free survival rate. N° de réf. du vendeur 9786204733814
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. CANCER STEM CELL MARKERS IN ORAL SQUAMOUS CELL CARCINOMA | Cancer Stem Cell Markers | Renu Yadav (u. a.) | Taschenbuch | Englisch | 2022 | LAP LAMBERT Academic Publishing | EAN 9786204733814 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 121163710
Quantité disponible : 5 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Cancer stem cells (CSCs; also known as tumour initiating cells) are a small population of cancer cells that retain characteristics similar to those of normal stem cells. CSCs are known to be responsible for metastasis, drug resistance and cancer recurrence. The lineages assumed by stem cells during hematopoiesis can be identified by the pattern of protein markers present on the surface of cells at different stages of differentiation. CSC surface markers provide molecular targeted therapies for various cancers, using therapeutic antibodies specific for the CSC surface markers. Moreover, the potential role of these cells in differentiation, treatment resistance, relapse and metastasis suggests that elimination of these cells can be a novel approach for oral cancer therapy. The combination of surgery, chemotherapy and radiation therapy has managed in controlling the disease, but overall the five year survival rate is poor. Hence along with these treatment modalities, controlling CSCs can prevent recurrence and increases overall disease free survival rate.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 136 pp. Englisch. N° de réf. du vendeur 9786204733814
Quantité disponible : 1 disponible(s)